Select Page

For more than 20 years, the Clinique médicale l’Actuel, under the direction of Dr. Réjean Thomas, has been bringing together healthcare professionals, with a focus in virology, to learn from guest experts and discuss the most relevant clinical practice challenges facing them today.

HIV Prevention: Non-Professional Post-Exposure Prophylaxis (PEP)

with Dr. Emmanuelle Huchet and Dr. Réjean Thomas

 

PROGRAM EXCERPT

HIGHLIGHTS

  • Non-professional PEP definition
  • Observational cohort of patients treated with non-professional PEP at the Clinique médicale l’Actuel
  • Non-professional PEP treatment guidelines

This activity is supported by
an educational grant from:

abbvie

SUMMARY

PARTICIPANTS

In this program, Dr. Emmanuelle Huchet sits down with Dr. Réjean Thomas from the Clinique médicale L’Actuel to discuss how non-professional PEP works, who it should be given to and when.

Dr. Thomas presents patient data from the Clinique médicale l’Actuel and discusses the various guidelines regarding the ideal non-professional PEP treatment.

Emmanuelle Huchet, MD

Emmanuelle Huchet, MD

Interviewer

Director, Clinical Services
Clinique médicale l’Actuel:
Centre of Excellence HIV– STI–Hepatitis
Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM)
Québec, Canada

Nimâ Machouf, PhD

Nimâ Machouf, PhD

Guest Speaker

Epidemiologist
Clinique médicale l’Actuel:
Centre of Excellence HIV– STI–Hepatitis
Quebec, Canada

Réjean Thomas, M.D., D.H.C.

Réjean Thomas, M.D., D.H.C.

Interviewee

CEO – Founder
Clinique médicale l’Actuel:
Centre of Excellence HIV–STI–Hepatitis
Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM)
Québec, Canada

COMPLETE PROGRAM

Only Logged in users can see the full program
DISCLOSURE

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.


Emmanuelle Huchet, MD has a financial interest/relationship or affiliation in the form of:
Consultant: AbbVie, Bristol-Myers Squibb, Janssen, Gilead, Merck, ViiV Healthcare.

Réjean Thomas, MD, DHC, has a financial interest/relationship or affiliation in the form of:
Advisory: AbbVie, Bristol-Myers Squibb Janssen, Gilead, Merck, ViiV Healthcare.


Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

[comment]